PetVivo Holdings IncOTCQB:PETV
- LAST PRICE0.5200
- TODAY'S CHANGE (%)0.0490 (10.4034%)
- Bid / Lots0.4670/ 25
- Ask / Lots0.5200/ 10
- Open / Previous Close0.4710 / 0.4710
- Day Range
- 52 Week Range
- Volume48,745
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | PETV |
|---|---|---|
| 10:26 ET | 13500 | 0.471 |
| 11:39 ET | 995 | 0.471 |
| 02:07 ET | 6500 | 0.471 |
| 02:09 ET | 3000 | 0.47 |
| 02:12 ET | 5500 | 0.47 |
| 02:38 ET | 10000 | 0.452 |
| 02:52 ET | 5000 | 0.46 |
| 03:21 ET | 3000 | 0.467 |
| 03:51 ET | 500 | 0.48 |
| 03:53 ET | 250 | 0.48 |
| 03:57 ET | 500 | 0.52 |
Nov 14, 2024
PetVivo Reports Fiscal Q2 2025 Results, from 4:00PM ET on Thursday Nov 14, 2024 by Dow Jones
4:00PM ET on Thursday Nov 14, 2024 by Dow Jones
Nov 11, 2024
PETVIVO HOLDINGS, INC. TO ANNOUNCE RESULTS FOR THE SECOND QUARTER ENDED SEPTEMBER 30, 2024, from 10:07AM ET on Monday Nov 11, 2024 by Dow Jones
10:07AM ET on Monday Nov 11, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
PetVivo Holdings Inc | 10.8M | -1.0x | --- |
REMSleep Holdings Inc | 11.8M | -6.4x | --- |
SeaStar Medical Holding Corp | 9.1M | -0.2x | --- |
Sigyn Therapeutics Inc | 8.7M | -1.8x | --- |
BioRegenx Inc | 13.2M | -2.4x | --- |
Dror Ortho-Design Inc | 14.4M | -1.2x | --- |
Company Information
PetVivo Holdings, Inc. is a biomedical device company focused on the manufacturing, commercialization and licensing of medical devices and therapeutics for companion animals. The Company has developed a pipeline of products for the medical treatment of animals and people, with a portfolio of 21 patents that protect the Company’s biomaterials, products, production processes and methods of use. Spryng with OsteoCushion Technology, its flagship product, is a veterinarian-administered, intra-articular injectable designed for the management of lameness and other joint related afflictions, including osteoarthritis, in cats, dogs and horses. It also has a pipeline that includes several therapeutic devices for both veterinary and human clinical applications. The Company manufactures its products in an ISO 7 certified clean room manufacturing facility in Minneapolis using its patented and scalable self-assembly production process. The Company may establish strategic out-licensing partnerships.
Contact Information
- Headquarters
- 5251 Edina Industrial BlvdEDINA, MN, United States 55439
- Phone
- 952-217-4952
- Fax
- 775-884-9383
Executives
- President, Chief Executive Officer, Director
- John Lai
- Chief Financial Officer
- Garry Lowenthal
- Chief Operating Officer
- Randall Meyer
- Vice President - Sales
- Bryan Monninger
- Chief Business Development Officer, General Counsel
- John Dolan
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $10.8M |
|---|---|
Revenue (TTM) | $968.6K |
Shares Outstanding | 20.9M |
PetVivo Holdings Inc does not pay a dividend. | |
Beta | 2.48 |
EPS | $-0.50 |
Book Value | $0.04 |
P/E Ratio | -1.0x |
Price/Sales (TTM) | 11.2 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -889.30% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
